These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7591484)

  • 1. Theoretical conformational analysis of three vasopressin antagonists with a modified cyclohexyl ring in the first thioacid residue.
    Kaźmierkiewicz R; Liwo A; Lammek B
    Int J Pept Protein Res; 1995 May; 45(5):451-8. PubMed ID: 7591484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical conformational analysis of six arginine vasopressin analogs with the L-naphthylalanine in position 3.
    Slusarz R; Kaźmierkiewicz R; Lammek B
    J Pept Res; 2000 Dec; 56(6):352-9. PubMed ID: 11152294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods.
    Liwo A; Tempczyk A; Ołdziej S; Shenderovich MD; Hruby VJ; Talluri S; Ciarkowski J; Kasprzykowski F; Lankiewicz L; Grzonka Z
    Biopolymers; 1996 Feb; 38(2):157-75. PubMed ID: 8589250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis of [Cpp1, Sar7, Arg8] vasopressin by 1H-NMR spectroscopy and molecular mechanics calculations.
    Shenderovich MD; Kasprzykowski F; Liwo A; Sekacis I; Saulitis J; Nikiforovich GV
    Int J Pept Protein Res; 1991 Dec; 38(6):528-38. PubMed ID: 1819587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanics calculations on deaminooxytocin and on deamino-arginine-vasopressin and its analogues.
    Liwo A; Tempczyk A; Grzonka Z
    J Comput Aided Mol Des; 1989 Jan; 2(4):281-309. PubMed ID: 2715790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of pressinoic acid: the cyclic moiety of vasopressin.
    Langs DA; Smith GD; Stezowski JJ; Hughes RE
    Science; 1986 Jun; 232(4755):1240-2. PubMed ID: 3704648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence study of neurohypophyseal hormones and their analogues. Distance distributions in a series of arginine-vasopressin analogues.
    Wiczk W; Lankiewicz L; Kasprzykowski F; Ołdziej S; Szmaciński H; Lakowicz JR; Grzonka Z
    Eur Biophys J; 1997; 26(2):183-93. PubMed ID: 9232846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation.
    Schmidt JM; Ohlenschläger O; Rüterjans H; Grzonka Z; Kojro E; Pavo I; Fahrenholz F
    Eur J Biochem; 1991 Oct; 201(2):355-71. PubMed ID: 1935933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational solution studies of (Sar7)desamino- and (MeAla7)desamino-vasopressin analogues using NMR spectroscopy.
    Rodziewicz-Motowidło S; Zhukov I; Kasprzykowski F; Grzonka Z; Ciarkowski J; Wójcik J
    J Pept Sci; 2002 Jul; 8(7):347-64. PubMed ID: 12148784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
    J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of natriferic activity of the vasopressin molecule by modifications in positions 1, 2 and 4.
    Bakos P; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1990 Dec; 9(6):605-13. PubMed ID: 2079200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
    Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical studies of the mechanism of the action of the neurohypophyseal hormones. I. Molecular electrostatic potential (MEP) and molecular electrostatic field (MEF) maps of some vasopressin analogues.
    Liwo A; Tempczyk A; Grzonka Z
    J Comput Aided Mol Des; 1989 Sep; 3(3):261-84. PubMed ID: 2585002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
    Mann WA; Stassen F; Huffman W; Kinter LB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of bulky 3,3'-diphenylalanine enantiomers replacing position 2 of AVP analogues on their conformations: NMR and molecular modeling studies.
    Sikorska E; Kwiatkowska A; Sobolewski D; Slusarz R; Slusarz MJ
    Eur J Med Chem; 2010 Sep; 45(9):4065-73. PubMed ID: 20580135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular dichroism studies of some arginine-vasopressin analogues.
    Grzonka Z; Gwizdała E; Kasprzykowski F; Lankiewicz L
    Biophys Chem; 1988 Aug; 31(1-2):87-100. PubMed ID: 3233295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of conformationally constrained amino acids replacing positions 2 and 3 of arginine vasopressin (AVP) and its analogues on their pharmacological properties.
    Sobolewski D; Prahl A; Derdowska I; Kwiatkowska A; Slaninová J; Lammek B
    Protein Pept Lett; 2007; 14(3):213-7. PubMed ID: 17346223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of conformationally restricted vasopressin analogues.
    Trzepałka E; Oleszczuk M; Maciejczyk M; Lammek B
    Acta Biochim Pol; 2004; 51(1):33-49. PubMed ID: 15094823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.